IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: A prospective and randomized study

Journal of Assisted Reproduction and Genetics

Volumn 26, Issue 2-3, 2009, Pages 105-111

  Ye, Hong ^a   Huang, Guo Ning ^a   Zeng, Ping Hong ^a   Pei, Li ^a  

^a Chongqing Obstetric and Gynecology Hospital   (China)

Author keywords

Controlled ovarian hyperstimulation; Estradiol pre treatment; FSH; IVF

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL VALERATE; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; BIRTH RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; FOLLITROPIN RELEASE; HUMAN; INCIDENCE; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; NIDATION; OOCYTE; OUTCOME ASSESSMENT; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION;

ADULT; CLINICAL PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; ESTROGENS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; LUTEAL PHASE; LUTEINIZING HORMONE; MALE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 62449255303     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-009-9300-3     Document Type: Article

References (18)

1. H Al-lnany M Aboulghar 2002 GnRH antagonist in assisted reproduction: a Cochcane review Hum Reprod. 17 874 85
2. JA Huirne R Homburg CB Lambalk 2007 Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod. 22 2805 13
3. F Devreker E Pogonici V De Maertelaer P Revelard M Vanden Bergh 1999 Selection of good embryos for transfer depends on embryo cohort size: implication for the mila ovarian stimulation debate Hum Reprod. 14 3002 8
4. MS Opsahl KL Blauor SH Black SR Lincoln L Thorell RJ Sherins 2001 The number of embryos available for transfer predicts successful pregnancy outcome in women over 39 years with normal ovarian hormonal reserve testing J Assist Reprod Genet. 18 551 6
5. R Fanchin JS Cunha-Filho LM Schonauer IJ Kadoch P Cohen-Bacri R Frydman 2003 Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation Fertil Steril. 79 316 21
6. R Fanchin L Salomon A Castelo-Branco F Olivennes N Frydman R Frydman 2003 Luteal estradiol pre-treatment coordinates folliclar growth during controlled ovarian hyperstimulation with antagonist Hum Reprod. 18 2698 703
7. R Fanchin JS Cunha-Filho LM Schonauer C Righini D de Ziegler R Frydman 2003 Luteal estradiol administration strengthens the relationship between day 3 follicle-stimulations hormone and inhibin B levels and ovarian follicular status Fertil Steril. 79 585 9
8. SY Chun KM Eisenhauer S Minami H Billig E Perlas AJ Hsueh 1996 Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone sa a major survival factor Endocrinology. 137 1447 56
9. NA Klein DE Battaglia VY Fujimoto GS Davis WJ Bremner MR Soules 1996 Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women J Clin Endocrinol Metab. 81 1038 45
10. SG Hillier AM Van den Boogaard LE Reichert Jr EV Van Hall 1980 Intraovarian sex steroia hormme interaction and the regulation of follicular maturation: aromatization of androgens by human granulose cells in vitro J Clin Endocrinol Metab. 50 4 640 7
11. I Durnerin-Cedrin B Bstandig L Parneix 2007 Effects of oral comfraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol Hum Reprod. 22 109 16
12. N Laholu N Chabbert-Buffer S Christin-Maitre E Le Nestour M Roger P Bouchard 1999 Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: inhibin A, Destradios, or inhibin B? Hum Reprod. 14 1190 3
13. G Borm B Mannaerts 2000 Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone in effective, safe and convenient: results of a controlled, randomize, multi-centre trial. The European Orgalutran Study Group Hum Reprod. 15 1490 8
14. H Al-Inany M Aboulghar 2002 GnRH antagonist in assisted reproduction: a Cochrane review Hum Reprod. 7 874 85
15. JAF Huime ACD van Loenen R Schats J McDonnell PGA Hompes J Schoemaker 2005 Dose-finding study of daily GnRH antagonist for the prevention of premature LHsurges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy Hum Reprod. 20 359 67
16. EM Kolibianakis K Zikopoulous J Schiettecatte J Smita H Tournaye M Camus 2004 Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF Hum Reprod. 19 2490 6
17. Rombauts L, Healy D, Norman RJ. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. On behalf of the Orgalutran Scheduling Study Group. Hum Reprod. 2006;21:95-103. doi: 10.1093/humrep/dei302.
18. EM Kolibianakis C Albano J Kahn M Camus H Tournaye AC Van Steirteghem 2003 Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is hv+mcnkjjassociatoal with a reduced chance of pregnancy Fertil Steril. 79 873 80